LX-2343
| CAS No. | 333745-53-2 | Cat. No. | BCP28952 |
| Name | LX-2343 | ||
| Synonyms | LX 2343; LX-2343; | ||
| Formula | C22H19ClN2O6S | M. Wt | 474.91 |
| Description | LX-2343 is a neuroprotective agent for the treatment of Alzheimer's disease. LX2343 ameliorates cognitive dysfunction in APP/PS1 transgenic mice via both Aβ production inhibition and clearance promotion, which highlights the potential of LX2343 in the treatment of AD. LX2343 ameliorates the cognitive dysfunction in the AD model rats by suppressing OS-induced neuronal apoptosis and tauopathy, thus highlighting the potential of LX2343 for the treatment of AD. | ||
| Pathways | Neuro Signaling Pathway Others Pathway PI3K/Akt/mTOR | ||
| Targets | Beta secretase Autophagy PI3K | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.